Pharma revenue management — the set of processes that turn a drug’s list price into realized net revenue after rebates, chargebacks, and government pricing obligations — has quietly become one...
B2B digital transformation has moved well past front-office tools like CRM and marketing automation. Today, it increasingly touches functions that were historically run on spreadsheets and...
Digital health tools and clinical research used to sit in separate worlds. Today they increasingly share data, patients, and technology platforms. This guide explains what connected health...
Biotechnology companies — particularly smaller and mid-sized ones — often reach a point where in-house expertise isn't enough to navigate commercial strategy, regulatory complexity, or market...
Key account management often gets treated as a sales discipline — something owned entirely by the commercial team, separate from broader company strategy. That framing undersells it. Your most...
Most product launch consulting engagements focus on positioning, messaging, and go-to-market sequencing — and rightly so. But one of the most common reasons a well-planned launch underperforms...
Bringing in outside expertise is rarely optional in life sciences — the regulatory bar is too high, the science too specialized, and the cost of a misstep too large to learn everything in-house....
Customers increasingly expect companies to understand their preferences and make interactions relevant. They do not necessarily expect every experience to be identical across channels. They...
Patient centricity has become one of those phrases that gets nodded along to in every pharma strategy deck, yet rarely gets defined precisely enough to act on. Most organizations agree it...
Pharmaceutical and medtech commercial teams have spent the past several years investing heavily in digital channels, personalization engines, and cross-functional field-marketing alignment. Yet...
Pharmaceutical companies are entering a period where commercial technology, not just molecule discovery, decides who wins market share. Patent cliffs, payer scrutiny, and shrinking launch...
Hospitals, payers, and life sciences companies are pouring resources into predictive analytics, diagnostic algorithms, and administrative automation, but few of them have the internal expertise...
